+

WO2001011969A1 - PROCEDE ENZYMATIQUE POUR TUER OU INHIBER DES CELLULES MICROBIENNES AVEC UN Ph ELEVE - Google Patents

PROCEDE ENZYMATIQUE POUR TUER OU INHIBER DES CELLULES MICROBIENNES AVEC UN Ph ELEVE Download PDF

Info

Publication number
WO2001011969A1
WO2001011969A1 PCT/DK2000/000451 DK0000451W WO0111969A1 WO 2001011969 A1 WO2001011969 A1 WO 2001011969A1 DK 0000451 W DK0000451 W DK 0000451W WO 0111969 A1 WO0111969 A1 WO 0111969A1
Authority
WO
WIPO (PCT)
Prior art keywords
haloperoxidase
detergent composition
detergent
bromide
composition according
Prior art date
Application number
PCT/DK2000/000451
Other languages
English (en)
Inventor
Charlotte Johansen
Original Assignee
Novozymes A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes A/S filed Critical Novozymes A/S
Priority to AU65581/00A priority Critical patent/AU6558100A/en
Publication of WO2001011969A1 publication Critical patent/WO2001011969A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/082—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances in combination with specific enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A61L2/186—Peroxide solutions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38654—Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/39—Organic or inorganic per-compounds
    • C11D3/3947—Liquid compositions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/395—Bleaching agents
    • C11D3/3956—Liquid compositions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/524—Preservatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/14—Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/17—Combination with washing or cleaning means

Definitions

  • the present invention relates to a very effective enzymatic method for killing or inhibiting microbial cells or microorganisms at high pH, more specifically microbial cells or microorganisms present in laundry, on hard surfaces, in water systems, m the pulp and paper industry, m the oil industry, on skin, teeth or mucous membranes; and for preserving food products, cosmetics, paints, coatings, etc.
  • WO 94/04127 discloses stabilized dentifrice compositions which are capable of producing antimicrobially effective concentrations of hypothiocyanite ions.
  • the compositions comprise an oxidoreductase capable of producing hydrogen peroxide and a peroxidase enzyme capable of oxidizing thiocyanate ions, which are normally present in saliva, to antimicrobial hypothiocyanite ions.
  • Suitable peroxidases include lactoperoxidase, myeloperoxidase, salivary peroxidase and chloroperoxidase .
  • EP-A-0 500 387 discloses enzymatic antimicrooial compositions comprising a haloperoxidase, e.g., myelo- peroxidase, eosinophil oxidase, lactoperoxidase and chloroperoxidase, which selectively binds to and inhibits the growth of target microorganisms in the presence of peroxide and halide.
  • a haloperoxidase e.g., myelo- peroxidase, eosinophil oxidase, lactoperoxidase and chloroperoxidase
  • WO 95/27046 discloses an antimicrobial composition comprising a Vanadium chloroperoxidase, halide ions, and hydrogen peroxide or a hydrogen peroxide-generating agent.
  • WO 96/38548 discloses an antimicrobial composition comprising a haloperoxidase, a halide ion, a peroxide generating agent and an amino acid type.
  • WO 97/09447 discloses an analytical composition for providing a chemiluminescent signal having a pH of from 6.5 to 10, comprising a chemiluminescent signal-generating reagent, a halogen, and a peroxide.
  • WO 97/31090 discloses a cleaning composition comprising a peroxidase, an enhancer and a source of hydrogen peroxide. The peroxidase is incorporated into a special release agent.
  • the ob j ect of the present invention is to provide a method for killing or inhibiting microbial cells at high pH, i.e., for disinfection or preservation, which is easy to use and an effective alternative to the known disinfecting and preserving compositions and methods.
  • the present invention provides, in a first aspect, a method for killing or inhibiting microbial cells comprising treating said microbial cells in an aqueous solution at a pH in the range of 8 to 11 with a haloperoxidase, a halide source selected from bromide and iodide, and a hydrogen peroxide source.
  • the method of the invention is useful as an antimicrobial treatment wherever such a treatment is needed, for example, for the preservation of food, beverages, cosmetics, deodorants, contact lens products, food ingredients or enzyme compositions; as a disinfection for use, e.g., on human or animal skin, hair, oral cavity, mucous membranes, wounds, bruises or in the eye; for killing microbial cells in laundry; and for disinfection of hard surfaces, in the pulp and paper industry, in the oil industry, or for water treatment.
  • the present invention provides a detergent composition
  • a detergent composition comprising a haloperoxidase, a halide source selected from bromide and iodide, a hydrogen peroxide source, and a surfactant, wherein said detergent composition in an aqueous solution has a pH in the range of 8 to 11.
  • composition of the invention is useful as an antimicrobial agent wherever such an agent is needed, for example, for the preservation of food, beverages, cosmetics, deodorants, contact lens products, food ingredients or enzyme compositions; as a disinfectant for use, e.g., on human or animal skin, hair, oral cavity, mucous membranes, wounds, bruises or m the eye; for killing microbial cells in laundry; and for incorporation in cleaning compositions or disinfectants for hard surface cleaning, in the pulp and paper industry, in the oil industry, for water treatment, or for disinfection.
  • the present invention provides a method of inhibiting microorganisms present m laundry, wherein the laundry is treated with the composition of the invention e.g. in a soaking, washing or rinsing liquor; a method of inhibiting microbial growth on a hard surface, wherein the surface is contacted with the composition of the invention; a method of inhibiting microbial cells present in industrial water lines; and a method of killing microbial cells present on human or animal skin, mucous membranes, teeth, wounds, bruises or in the eye or inhibiting the growth thereof, wherein the cells to be killed or inhibited on the skin, mucous membrane, teeth, wound or bruise are/is contacted with the composition of the invention.
  • antimicrobial is intended to mean that there is a bactericidal and/or a bacteriostatic and/or fungicidal and/or fungistatic effect and/or a virucidal effect, wherein
  • bacteria is to be understood as capable of killing bacterial cells.
  • bacteriostatic is to be understood as capable of inhibiting bacterial growth, i.e. inhibiting growing bacterial cells.
  • fungicidal is to be understood as capable of killing fungal cells.
  • fungistatic is to be understood as capable of inhibiting fungal growth, i.e. inhibiting growing fungal cells.
  • viral is to be understood as capable of inactivating virus.
  • microbial cells denotes bacterial or fungal cells
  • microorganism denotes a fungus (including yeasts) or a bacterium.
  • the term "inhibiting growth of microbial cells” is intended to mean that the cells are in the non-growing state, i.e., that they are not able to propagate.
  • log reduction is defined as a logarithmic reduction of the number of living cells, e.g. 1 log reduction corresponds to a reduction in living cell number of Escherichia coli DSM1576 or Ent ⁇ rococcus faecalis DSM2570 from Y x 10 x CFU/M (CFU: Colony Forming Units, M: ml or g) to Y x lO "1 CFU/M, where X can be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11, and Y can be any number from 0 to 10.
  • the number of living bacteria is to be determined as the number of E. coli or E. faecalis, respectively, which can grow on Tryptone Soya Agar (#CM129, Oxoid, England) plates at 30°C.
  • hard surface as used herein relates to any surface which is essentially non-permeable for microorganisms.
  • hard surfaces are surfaces made from metal, e.g., stainless steel, plastics, rubber, board, glass, wood, paper, textile, concrete, rock, marble, gypsum and ceramic materials which optionally may be coated, e.g., with paint, enamel and the like.
  • the hard surface can also be a process equipment, e.g., a cooling tower, an osmotic membrane, a water treatment plant, a dairy, a food processing plant, a chemical plant, a pharmaceutical process plant, a pulp and paper plant or an oil processing plant. Accordingly, the composition according to the present invention is useful in a conventional cleaning-in-place (C-I-P) system.
  • C-I-P cleaning-in-place
  • haloperoxidase is intended to mean an enzyme selected from the group consisting of chloride peroxidase (EC 1.11.1.10), bromide peroxidase, and iodide peroxidase (EC 1.11.1.8), preferably “haloperoxidase” is a bromide peroxidase.
  • a chloride peroxidase is an enzyme capable of oxidizing chloride, bromide and iodide ions with the consumption of H 2 0 2 .
  • a bromide peroxidase is an enzyme capable of oxidizing bromide and iodide ions with the consumption of H 2 0 2 .
  • a iodide peroxidase is an enzyme capable of oxidizing iodide ions with the consumption of H 2 0 2 .
  • Vanadium haloperoxidases are preferred. Vanadium haloperoxidases are different from other haloperoxidases m that the prosthetic group in theses enzymes has structural features similar to vanadate (vanadium V) and contain vanadium, whereas the other haloperoxidases are hemeperoxidases .
  • the Vanadium haloperoxidases disclosed in WO 95/27046 are preferred.
  • Haloperoxidases have been isolated from various organisms: mammals, marine animals, plants, algae, a lichen, fungi and bacteria (for reference see Biochimica et Biophysica Acta 1161,
  • haloperoxidase is obtained from fungi, bacteria or algae. It is generally accepted that haloperoxidases are the enzymes responsible for the formation of halogenated compounds in nature, although other enzymes may be involved.
  • Haloperoxidases have been isolated from many different fungi, in particular from the fungus group dematiaceous hypho- mycetes, such as Caldariomyces, e.g., C. fumago, Al terna ⁇ a , Curvula ⁇ a , e.g., C. verruculosa and C. maequalis, Drechslera , e.g., D. hartlebn, Ulocladium, Phaeot ⁇ choconis, e.g., P. crotala ⁇ ae, Gemculosporium, Dendryphiella, e.g., D. salma , and Botrytis (see US Patent No. 4,937,192).
  • Caldariomyces e.g., C. fumago, Al terna ⁇ a , Curvula ⁇ a , e.g., C. verruculosa and C. maequalis
  • Drechslera e.g.,
  • a haloperoxidase obtainable from Curvula ⁇ a in particular C. verruculosa is preferred such as C. verruculosa CBS 147.63 or C. verruculosa CBS 444.70, or a haloperoxidase which is lmnaunologically cross- reactive with C. verruculosa CBS 147.63.
  • Curvula ⁇ a haloperoxidase and recombinant production hereof is described in WO 97/04102.
  • SEQ ID NO:l and SEQ ID NO:2 of the present invention are also described m WO 97/04102.
  • Haloperoxidase has also been isolated from bacteria such as Pseudomonas, e.g., P. pyrrocima (for reference see The Journal of Biological Chemis try 263, 1988, pp. 13725-13732) and Streptomyces , e.g., S . a ureofaciens (for reference see Struc- tural Biology 1 , 1994, pp. 532-537).
  • Pseudomonas e.g., P. pyrrocima
  • Streptomyces e.g., S . a ureofaciens
  • Bromide peroxidase has been isolated from algae (see US Patent No. 4,937,192) .
  • the haloperoxidase of the invention is an isolated polypeptide having an ammo acid sequence which has a degree of identity to the ammo acid sequence of SEQ ID NO:2 of at least about 60%, preferably at least about 70%, more preferably at least about 80%, most preferably at least about 90%, and in particular at least about 95%, and have haloperoxidase activity (hereinafter "homologous haloperoxidases").
  • the homologous haloperoxidases have an amino acid sequence which differs by five am o acids, preferably by four ammo acids, more preferably by three ammo acids, even more preferably by two ammo acids, and most preferably by one ammo acid from the amino acid sequence of SEQ ID NO: 2.
  • the degree of identity between two ammo acid sequences is determined by using GAP version 8 from the GCG package (Genetics Computer Group, 575 Science Drive, Madison, WI 53711, USA) with standard penalties for proteins: GAP weight 3.00, length weight 0.100, Matrix described m Gribskov and Burgess, Nucl . Acids Res. 14(16); 6745-6763 (1986).
  • the haloperoxidases of the present invention comprise the amino acid sequence of SEQ ID NO: 2 or a fragment thereof that has haloperoxidase activity.
  • the haloperoxidases of the present invention comprise the ammo acid sequence of SEQ ID NO: 2.
  • the haloperoxidases of the present invention consist of the amino acid sequence of SEQ ID NO: 2 or a fragment thereof that has haloperoxidase activity.
  • the haloperoxidases of the present invention consists of the ammo acid sequence of SEQ ID NO: 2.
  • the concentration of the haloperoxidase may be varied m order to achieve the desired antimicrobial effect in the desired time frame.
  • the haloperoxidase will normally be present in a concentration of 0.01-100 mg enzyme protein per liter, preferably m a concentration of 0.05-10 mg enzyme protein per liter, more preferably in a concentration of 0.1-5 mg enzyme protein per liter, and most preferably m a concentration of 0.1-1 mg enzyme protein per liter.
  • the hydrogen peroxide needed for the reaction with the haloperoxidase may be achieved in many different ways: It may be hydrogen peroxide or a hydrogen peroxide precursor, such as, e.g., percarbonate or perborate, or a peroxycarboxylic acid or a salt thereof, or it may be a hydrogen peroxide generating enzyme system, such as, e.g., an oxidase and its substrate.
  • Useful oxidases may be, e.g., a glucose oxidase, a glycerol oxidase or an ammo acid oxidase.
  • An example of an amino acid oxidase is given in WO 94/25574.
  • the hydrogen peroxide source needed for the reaction with the haloperoxidase may be present in a concentration corresponding to a hydrogen peroxide concentration in the range of from 0.01-1000 mM, preferably in the range of from 0.05-500 mM, more preferably in the range of from 0.1-100 mM, even more preferably in the range of from 0.5- 50 mM, and most preferably m the range of from 1-10 mM.
  • the halide source needed for the reaction with the haloperoxidase is selected from bromide and iodide, preferably the halide source is bromide. It may be achieved in many different ways, e.g., by adding a bromide salt and/or a iodide salt: e.g., sodium bromide, potassium bromide, sodium iodide, or potassium iodide.
  • the halide source will typically be present m a concentration corresponding to 0.01-1000 mM halide, preferably corresponding to 0.05-500 mM halide, more preferably corresponding to 0.1-100 mM halide, even more preferably corresponding to 0.5-50 mM halide, and most preferably corresponding to 1-10 mM halide.
  • the method provides a method for killing or inhibiting microbial cells comprising treating said microbial cells m an aqueous solution at a pH m the range of 8 to 11 with:
  • haloperoxidase - a halide source selected from bromide and iodide
  • a method of killing or inhibiting microorganisms present laundry wherein the laundry is treated with a soaking, washing or rinsing liquor comprising an effective amount of the detergent composition of the invention.
  • the laundry is treated in a washing machine .
  • an effective amount of the detergent composition of the invention is incorporated into the cosmetic product; and a method of cleaning, disinfecting or inhibiting microbial growth on a hard surface, wherein the surface is contacted with the detergent composition of the invention.
  • an effective amount is meant an amount suitable for obtaining the required antimicrobial activity in the chosen application; e.g. to reduce the number of living cells to 10%, 1% or less than 1%; or to prevent the number of living cells from doubling during 12 hours, 1 day, 5 days, 30 days or more than 30 days
  • the methods of the invention When the methods of the invention are applied, they result in an antimicrobial activity of at least 1 log reduction, preferably an antimicrobial activity of at least 2 log reductions, and more preferably an antimicrobial activity of at least 3 log reductions .
  • treatment with the hydrogen peroxide component can be done separately from treatment with the other components.
  • the methods of the invention may further comprise treatment with auxiliary agents such as wetting agents, thickening agents, buffer, stabilisers, perfume, colourants, fillers and the like.
  • auxiliary agents such as wetting agents, thickening agents, buffer, stabilisers, perfume, colourants, fillers and the like.
  • useful wetting agents are surfactants, i.e., non-ionic, anionic, amphoteric or zwitte ⁇ onic surfactants.
  • the term "treating" comprise contacting, reacting, acting on, or in other ways having an effect on.
  • the pH of the methods of the invention is in the range of from pH 8 to 11, preferably in the range of from pH 8.6 to 10.5, more preferably in the range of from pH 9 to 10.5, and most preferably m the range of from pH 9 to 10.
  • the detergent composition comprising the haloperoxidase, the hydrogen peroxide source, the halide source, and the surfactant preferably has an antimicrobial activity of at least 1 log reduction, more preferably an antimicrobial activity of at least 2 log reductions, and most preferably an antimicroDial activity of at least 3 log reductions.
  • the detergent composition may be formulated as a solid or a liquid.
  • all components may be mixed together, e.g., as a powder, a granulate, a gelled, or a dry product .
  • composition of the invention may further comprise auxiliary agents such as wetting agents, thickening agents, buffer, stabilisers, perfume, colourants, fillers and the like.
  • auxiliary agents such as wetting agents, thickening agents, buffer, stabilisers, perfume, colourants, fillers and the like.
  • useful wetting agents are surfactants, i.e., non-ionic, anionic, amphoteric or zwitterionic surfactants.
  • the composition of the invention may be a concentrated product or a ready-to-use product.
  • the concentrated product is typically diluted with water to provide a medium having an effective antimicrobial activity, applied to the object to be disinfected or preserved, and allowed to react with the micro-organisms present.
  • the pH of a 1% aqueous solution of the composition is in the range of from pH 8 to 11, preferably m the range of from pH 8.6 to 10.5, more preferably m the range of from pH 9 to 10.5, and most preferably in the range of from pH 9 to 10.
  • composition of the invention may also be formulated as a two part system wherein one part is the haloperoxidase and the surfactant; the other part is the hydrogen peroxide source; and the halide source may then come from tap water or otherwise be naturally present.
  • the haloperoxidase, halide source and hydrogen peroxide source (hereinafter denoted “the antimicrobial system”) of the invention may be incorporated into a detergent or cleaning composition comprising more enzyme types useful in detergent or cleaning compositions, preferably at least one further enzyme selected from the group consisting of proteases, carbohydrases, amylases, cutmases, peroxidases, oxidases, laccases, cellulases, pectmase, mannanases, arabmases, galactanases, xylanases, and lipases.
  • composition used in the method of the present invention may be incorporated into the e.g. unpreserved food, beverages, cosme- tics, contact lens products, food ingredients or anti flammatory product in an amount effective for killing or inhibiting growth of microbial cells.
  • composition used in the method of the invention may by useful as a disinfectant, e.g., m the treatment of acne, infections in the eye or the mouth, skin infections; in antiperspirants or deodorants; in foot bath salts; for cleaning and disinfection of contact lenses, hard surfaces, teeth (oral care), wounds, bruises and the like.
  • a disinfectant e.g., m the treatment of acne, infections in the eye or the mouth, skin infections; in antiperspirants or deodorants; in foot bath salts; for cleaning and disinfection of contact lenses, hard surfaces, teeth (oral care), wounds, bruises and the like.
  • the composition may also be used for the manufacture of a medicament for therapeutic treatment, such as the treatments mentioned above.
  • composition of the present invention is useful for cleaning, disinfecting or inhibiting microbial growth on any hard surface.
  • surfaces which may advantageously be contacted with the composition of the invention are surfaces of process equipment used n e.g. dairies, chemical or pharmaceutical process plants, water sanitation systems, oil processing plants, paper pulp processing plants, water treatment plants, and cooling towers.
  • the composition of the invention should be used in an amount, which is effective for cleaning, disinfecting or inhibiting microbial growth on the surface question.
  • composition of the invention can advantageously be used in a cleaning-in-place (C.I. P.) system for cleaning of process equipment of any kind.
  • C.I. P. cleaning-in-place
  • the method of the invention may additionally be used for cleaning surfaces and cooking utensils in food processing plants and any area in which food is prepared or served such as hospitals, nursing homes, restaurants, especially fast food restaurants, delicatessens and the like. It may also be used as an antimicrobial in food products and would be especially useful as a surface antimicrobial cheeses, fruits and vegetables and food on salad bars.
  • It may also be used as a preservation agent or a disinfection agent in water based paints.
  • composition of the present invention is also useful for microbial control of water lines, and for disinfection of water, m particular for disinfection of industrial water.
  • Detergent Compositions are also useful for microbial control of water lines, and for disinfection of water, m particular for disinfection of industrial water.
  • the antimicrobial system of the invention may be added to and thus become a component of a detergent composition.
  • the detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre- treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use m general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
  • the invention provides a detergent additive comprising the antimicrobial system of the invention and a surfactant.
  • the detergent additive as well as the detergent composition may comprise one or more other enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabmase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
  • the properties of the chosen enzyme (s) should be compatible with the selected detergent, (i.e.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
  • the protease may be a se ⁇ ne protease or a metallo protease, preferably an alkaline microbial protease or a trypsm-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacill us, e.g., subtilism Novo, subtilism Carlsberg, subtilism 309, subtilism 147 and subtilism 168 (described in WO 89/06279).
  • trypsm- like proteases are trypsm (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
  • Examples of useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
  • Preferred commercially available protease enzymes include AlcalaseTM, Sav aseTM, P ⁇ maseTM, DuralaseTM, EsperaseTM, and KannaseTM (Novo Nordisk A/S) , MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, and FN3TM (Genencor International Inc.).
  • Lipases Suitable l pases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humi cola (synonym Thermomyces ) , e.g. from H. lanugmosa [ T .
  • lanugmosus as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580
  • a Pseudomonas lipase e.g. from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutze ⁇ (GB 1,372,034), P. fluorescens, Pseudomonas sp . strain SD 705 (WO 95/06720 and WO 96/27002), P. wisconsmensis (WO 96/12012), a Bacillus lipase, e.g. from B .
  • subtilis (Dartois et al . (1993), Biochemica et Biophysica Acta, 1131, 253-360), B . stearothermophilus (JP 64/744992) or B . pumilus (WO 91/16422) .
  • lipase variants such as those described m WO 92/05249, WO 94/01541, EP 407 225, EP 260 105, WO 95/35381, WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
  • Preferred commercially available lipase enzymes include LipolaseTM and Lipolase UltraTM (Novo Nordisk A/S) .
  • Amylases Suitable amylases ( and/or ⁇ ) include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, ⁇ -amylases obtained from Bacill us, e.g. a special strain of B . licheniformis, described m more detail in GB 1,296,839.
  • Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions m one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391, 408, and 444.
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacill us , Pseudomonas , Humicola , Fusarium, Thielavia , Acremonium, e.g.
  • cellulases are the alkaline or neutral cellulases having colour care benefits.
  • Examples of such cellu- lases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940.
  • Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471, WO 98/12307 and PCT/DK98/00299.
  • Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Cop ⁇ nus, e.g. from C. cmereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include GuardzymeTM (Novo Nordisk A/S) .
  • the detergent enzyme (s) may be included m a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
  • a detergent additive of the invention i.e. a separate additive or a combined additive, can be formulated e.g. as a granulate, a liquid, a slurry, etc.
  • Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slur ⁇
  • Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and 4,661,452 and may optionally be coated by methods known in the art.
  • waxy coating materials are poly (ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and m which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglyce ⁇ des of fatty acids.
  • poly (ethylene oxide) products polyethyleneglycol, PEG
  • mean molar weights 1000 to 20000
  • ethoxylated nonylphenols having from 16 to 50 ethylene oxide units
  • Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
  • Protected enzymes may be prepared according to the method disclosed in EP 238,216.
  • the detergent composition of the invention may be m any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid.
  • a liquid detergent may be aqueous, typically containing up to 70 % water and 0-30 % organic solvent, or non- aqueous .
  • the detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or aniomc and/or catiomc and/or zwitterionic.
  • the surfactants are typically present at a level of from 0.1% to 60% by weight.
  • the detergent When included therein the detergent will usually contain from about 1% to about 40% of an aniomc surfactant such as linear alkylbenzenesulfonate, alpha-olef sulfonate, alkyl sulfate (fatty alcohol sulfate) , alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsucc ic acid or soap.
  • an aniomc surfactant such as linear alkylbenzenesulfonate, alpha-olef sulfonate, alkyl sulfate (fatty alcohol sulfate) , alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsucc ic acid or soap.
  • the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylam eoxide, ethoxylated fatty acid monoethanol- amide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamme (“glucamides”) .
  • a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylam eoxide, ethoxylated fatty acid monoethanol- amide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamme (“glucamides”) .
  • a non-ionic surfactant such as alcohol
  • the detergent may contain 0-65 % of a detergent builder or complexmg agent such as zeolite, diphosphate, t ⁇ phosphate, phosphonate, carbonate, citrate, nit ⁇ lotriacetic acid, ethylenediammetetraacetic acid, diethylenet ⁇ ammepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst) .
  • the detergent may comprise one or more polymers. Examples are carboxymethylcellulose, poly (vinylpyrrolidone) , poly
  • polycarboxylates such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent may contain a bleaching system which may comprise a H 2 0 2 source such as perborate or percarbonate which may be combined with a peracid-formmg bleach activator such as tetraacetylethylenediamme or nonanoyloxybenzenesulfonate .
  • the bleaching system may comprise peroxyacids of e.g. the amide, lmide, or sulfone type.
  • the enzyme (s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in e.g. WO 92/19709 and WO 92/19708.
  • the detergent may also contain other conventional detergent ingredients such as e.g.
  • fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil- suspendmg agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • any enzyme in particular the haloperoxidase of the invention, may be added in an amount corresponding to 0.01-100 mg cf enzyme protein per liter of wash liqour, preferably 0.05- 10 mg of enzyme protein per liter of wash liqour, more preferably 0.1-5 mg of enzyme protein per liter of wash liqour, and most preferably 0.1-1 mg of enzyme protein per liter of wash liqour.
  • the antimicrobial system of the invention may additionally be incorporated m the detergent formulations disclosed m WO 97/07202 which is hereby incorporated as reference.
  • the Malthus Flexi M2060 instrument is available from Malthus
  • Curvula ⁇ a verruculosa recombmant peroxidase is available from Novo Nordisk A/S, Denmark.
  • NOPA V0054 powder detergent is available from Nordisk Detergent
  • the buffers (0.0005 M) used were: pH 5 Homopipes (#6047H, Research Organics, U.S.) pH 6 MES (#M2250, Sigma) pH 7 HEPES (#H3375, Sigma) pH 8 HEPES (#H3375, Sigma) pH 9 HEPES (#H3375, Sigma) + CAPS (#C2632, Sigma] pH 10: CAPS (#C2632, Sigma)
  • log reduction is defined as a logarithmic reduction of the number of living cells, e.g. 1 log reduction corresponds to a reduction in living cell number of Escherichia coli DSM1576 or Enterococcus faecalis DSM2570 from Y x 10 x CFU/M (CFU: Colony Forming Units, M: ml or g) to Y x 10 x"1 CFU/M, where X can be 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11, and Y can be any number from 0 to 10.
  • the number of living toacte ⁇ a are to be determined as the number of E . coli or E . faecal is , respectively, which can grow on Tryptone Soya Agar plates at 30°C.
  • Curvula ⁇ a verruculosa reco bmant peroxidase was evaluated at pH 5-10 with chloride, iodide and bromide as halide sources.
  • the antibacterial activity of haloperoxidase (1 mg/1) was tested against Staphylococcus epidermidis DSM20042 with sodium chloride (80 mM) as electron donor, and hydrogen peroxide (0.5 mM) was added as electron acceptor in the presence of NH 4 + (8 mM) .
  • iodide (0.5 mM) or bromide (4 mM) was used as halide source, no NH 4 + was present.
  • S . epidermidis was grown Brain
  • BHI Heart Infusion Broth
  • the bactericidal activity was determined by incubation in a Malthus instrument. The detection times measured by the Malthus instrument were converted to CFU/ml by a calibration curve. Either direct or indirect Malthus measurements were used when enumerating total survival cells. By the direct measurements, the cell metabolism was determined by conductance measurements in the growth substrate. By the indirect measurements, 3 ml of growth medium was transferred to the outer chamber of the indirect Malthus cells, and 0.5 ml of sterile KOH (0.1 M) was transferred to the inner chamber. The cell suspensions were after enzyme treatment transferred to the outer chamber of the Malthus cell.
  • Antibacterial activity m detergent of haloperoxidase using bromide as electron donor
  • the antibacterial activity of haloperoxidase (rCvP) was tested in NOPA V0054 powder detergent. pH of the detergent was measured as approximately 9.9, antimicrobial activity was evaluated in the detergent at pH 9.9, 9, and 8 where pH was adjusted. Antimicrobial activity was determined by using a factorial experimental design (2*3 4 factorial experiment) where the factors are rCvP (0, 0.5, 1 mg/1), KBr (0, 4, 8 mM) , (NH 4 ) 2 S0 4 (0, 1, 2 mM) and H 2 0 2 (0, 0.5, 1 mM) .
  • Microbial cells Esche ⁇ chia col i DSM1576 and En terococcus faecalis DSM2570 were grown over night in Tryptone Soy Broth, these two strains was not found to be sensitive to the detergent when no enzyme was present.
  • Cells were suspended NOPA detergent (6 g/L) to the cell concentration of approximately 10 ⁇ -10 8 CFU/ml, followed by addition of the enzyme system. After incubation at 35°C for 12 mm, the number of living microorganisms was determined by use of a Malthus instrument. Results obtained without NH 4 + are shown in table 2. A total kill of both E. coli and E .
  • faecalis was obtained in the detergent when the bromide system (KBr, rCvP, H 2 0 2 ) was present, and no significant activity was obtained in the controls where one or two of the compounds were missing. When NH 4 + was present the antimicrobial activity was increased.
  • Antibacterial activity in detergent of haloperoxidase using bromide, chloride and iodide as electron donor The antibacterial activity of haloperoxidase (rCvP) was tested in NOPA 2 powder detergent. pH of the detergent was adjusted to pH 8 or 9 and antimicrobial activity was evaluated in the detergent as described above. Antimicrobial activity was determined by using a factorial experimental design (2*2 3 factorial experiment) where the factors are rCvP (0 and 5 mg/L) ; halide: KBr, KC1, KI (0 and 2 mM) ; H 2 0 2 (0 and 0.5 mM) .
  • Microbial cells Esche ⁇ chia col i DSM1576 and En terococcus faecalis DSM2570 were grown over night in Tryptone Soy Broth, these two strains were found not to be sensitive to the detergent when no enzyme was present.
  • Cells were suspended in NOPA 2 (5 g/L) to the cell concentration of approximately 10 7 - 10 8 CFU/ml, followed by addition of the enzyme system. After incubation at 40°C for 20 mm, the number of living microorganisms was determined by use of Malthus. Results are shown in table 3. A total kill of both E . coli and E .
  • faecalis was obtained in the detergent at both pH 8 and 9 when the bromide system (KBr, rCvP, H 2 0 2 ) was present, and no significant activity was obtained in the controls where one or two of the compounds were missing.
  • Chloride resulted in a very low bactericidal activity at high pH, whereas Iodide resulted in a significant kill, however, iodide was also slightly bactericidal by oxidation by hydrogen peroxide without enzyme.
  • bromide as enhancer was significantly more bactericidal than iodide and chloride in detergent at high pH .
  • the antibacterial activity of four haloperoxidases was tested in NOPA 2 powder detergent. pH of the detergent was measured and antimicrobial activity of the haloperoxidases was determined in the detergent solution as well as in a borate buffer (0.05 M) with the same pH as the detergent solution (pH 9.8). Antimicrobial activity was determined by using a factorial experimental design (2*2 3 factorial experiment with center points) where the factors are haloperoxidase (0 and 5 mg/L), KBr (0 and 8 mM) , and H 2 0 2 (0 and 1 mM) . The following haloperoxidases were compared: Phaeotrichoconis crotalariae (DSM13441), Geniculosporium sp .
  • DSM13442 Dendryphiella salina (DSM13443) and Curvularia verruculosa (rCvP) .
  • Microbial cells ⁇ Escherichia coli DSM1576) were grown over night in Tryptone Soy Broth. Cells were washed in saline and suspended in NOPA 2 (5 g/L) to the cell concentration of approximately 10 7 -10 8 CFU/ml, followed by addition of the enzyme system, or cells were suspended in the borate buffer. After incubation at 40°C for 20 min, the number of living microorganisms was determined by use of Malthus. Results are shown in table 4. A significantly higher bactericidal activity was determined in detergent compared to buffer, thus a synergistic effect was observed when combining haloperoxidases with detergent.
  • ** corresponds to a total kill in one of the doublets

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Emergency Medicine (AREA)
  • Detergent Compositions (AREA)

Abstract

L'invention concerne un procédé enzymatique pour tuer ou inhiber des cellules microbiennes avec un pH élevé, qui consiste à utiliser une haloperoxydase, une source de peroxyde d'hydrogène et une source de bromure et/ou d'iodure.
PCT/DK2000/000451 1999-08-13 2000-08-11 PROCEDE ENZYMATIQUE POUR TUER OU INHIBER DES CELLULES MICROBIENNES AVEC UN Ph ELEVE WO2001011969A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU65581/00A AU6558100A (en) 1999-08-13 2000-08-11 Enzymatic method for killing or inhibiting microbial cells at high ph

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901126 1999-08-13
DKPA199901126 1999-08-13

Publications (1)

Publication Number Publication Date
WO2001011969A1 true WO2001011969A1 (fr) 2001-02-22

Family

ID=8101307

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2000/000451 WO2001011969A1 (fr) 1999-08-13 2000-08-11 PROCEDE ENZYMATIQUE POUR TUER OU INHIBER DES CELLULES MICROBIENNES AVEC UN Ph ELEVE

Country Status (2)

Country Link
AU (1) AU6558100A (fr)
WO (1) WO2001011969A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041667A3 (fr) * 2001-11-13 2003-07-31 Procter & Gamble Compositions contenant des enzymes stabilisees a l'aide de certains osmoprotecteurs et methodes d'utilisation de ces compositions dans des soins d'hygiene personnelle
US7661281B2 (en) 2004-11-22 2010-02-16 3M Innovative Properties Company Method and device for shaping an orthodontic archwire
US7751925B2 (en) 2006-01-27 2010-07-06 3M Innovative Properties Company System to manufacture custom orthodontic appliances, program product, and related methods
US7811087B2 (en) 2002-02-13 2010-10-12 3M Innovative Properties Company Modular system for customized orthodontic appliances
USRE42815E1 (en) 2002-11-06 2011-10-11 3M Innovative Properties Company Method and system for customizing an orthodontic archwire
WO2015003913A1 (fr) * 2013-07-11 2015-01-15 Unilever N.V. Composition de détergent
WO2015003911A1 (fr) * 2013-07-11 2015-01-15 Unilever N.V. Composition de détergent
WO2015003912A1 (fr) * 2013-07-11 2015-01-15 Unilever N.V. Composition de détergent
CN115279187A (zh) * 2019-12-09 2022-11-01 斯莱戈理工学院 抗微生物组合物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027046A2 (fr) * 1994-03-31 1995-10-12 Unilever Nv Compositions antimicrobiennes enzymatiques comprenant des haloperoxydases
WO1996005730A1 (fr) * 1994-08-22 1996-02-29 Symbollon Corporation Germicide a base d'iode et procede de mise en oeuvre
WO1996038548A1 (fr) * 1995-06-01 1996-12-05 Eoe, Inc. Formules activees par oxygene pour la desinfection ou la sterilisation
WO1997004102A1 (fr) * 1995-07-14 1997-02-06 Novo Nordisk A/S Haloperoxydases provenant de curvularia verruculosa et acides nucleiques les codant
WO1997042825A1 (fr) * 1996-05-09 1997-11-20 Novo Nordisk A/S Compositions antimicrobiennes de peroxydase
WO1999008531A1 (fr) * 1997-08-14 1999-02-25 Novo Nordisk A/S Composition antibicrobienne contenant une haloperoxydase, une source de peroxyde d'hydrogene, une source d'halogenure, et une source d'ammonium

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027046A2 (fr) * 1994-03-31 1995-10-12 Unilever Nv Compositions antimicrobiennes enzymatiques comprenant des haloperoxydases
WO1996005730A1 (fr) * 1994-08-22 1996-02-29 Symbollon Corporation Germicide a base d'iode et procede de mise en oeuvre
WO1996038548A1 (fr) * 1995-06-01 1996-12-05 Eoe, Inc. Formules activees par oxygene pour la desinfection ou la sterilisation
WO1997004102A1 (fr) * 1995-07-14 1997-02-06 Novo Nordisk A/S Haloperoxydases provenant de curvularia verruculosa et acides nucleiques les codant
WO1997042825A1 (fr) * 1996-05-09 1997-11-20 Novo Nordisk A/S Compositions antimicrobiennes de peroxydase
WO1999008531A1 (fr) * 1997-08-14 1999-02-25 Novo Nordisk A/S Composition antibicrobienne contenant une haloperoxydase, une source de peroxyde d'hydrogene, une source d'halogenure, et une source d'ammonium

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
R.I. LEHRER: "Antifungal effects of peroxidase systems", JOURNAL OF BACTERIOLOGY, vol. 99, no. 2, August 1969 (1969-08-01), pages 361 - 365, XP002933683 *
SEYMOUR C. KLEBANOFF: "Myeloperoxidase-halide-hydrogen peroxide antibacterial system", JOURNAL OF BACTERIOLOGY, vol. 95, no. 6, June 1968 (1968-06-01), pages 2131 - 2138, XP002933682 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041667A3 (fr) * 2001-11-13 2003-07-31 Procter & Gamble Compositions contenant des enzymes stabilisees a l'aide de certains osmoprotecteurs et methodes d'utilisation de ces compositions dans des soins d'hygiene personnelle
US10136965B2 (en) 2002-02-13 2018-11-27 3M Innovative Properties Company Customized orthodontic bracket system
US7811087B2 (en) 2002-02-13 2010-10-12 3M Innovative Properties Company Modular system for customized orthodontic appliances
US7850451B2 (en) 2002-02-13 2010-12-14 3M Innovative Properties Company Modular system for customized orthodontic appliances
US8057226B2 (en) 2002-02-13 2011-11-15 3M Innovative Properties Company Customized orthodontic bracket system
USRE42815E1 (en) 2002-11-06 2011-10-11 3M Innovative Properties Company Method and system for customizing an orthodontic archwire
USRE44668E1 (en) 2002-11-06 2013-12-24 3M Innovative Properties Company Method and system for customizing an orthodontic archwire
US7661281B2 (en) 2004-11-22 2010-02-16 3M Innovative Properties Company Method and device for shaping an orthodontic archwire
US7751925B2 (en) 2006-01-27 2010-07-06 3M Innovative Properties Company System to manufacture custom orthodontic appliances, program product, and related methods
WO2015003913A1 (fr) * 2013-07-11 2015-01-15 Unilever N.V. Composition de détergent
WO2015003912A1 (fr) * 2013-07-11 2015-01-15 Unilever N.V. Composition de détergent
CN105357969A (zh) * 2013-07-11 2016-02-24 荷兰联合利华有限公司 洗涤剂组合物
CN105451560A (zh) * 2013-07-11 2016-03-30 荷兰联合利华有限公司 洗涤剂组合物
CN105451560B (zh) * 2013-07-11 2018-04-24 荷兰联合利华有限公司 洗涤剂组合物
CN105357969B (zh) * 2013-07-11 2018-05-29 荷兰联合利华有限公司 洗涤剂组合物
WO2015003911A1 (fr) * 2013-07-11 2015-01-15 Unilever N.V. Composition de détergent
CN115279187A (zh) * 2019-12-09 2022-11-01 斯莱戈理工学院 抗微生物组合物

Also Published As

Publication number Publication date
AU6558100A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
US6251386B1 (en) Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
US20020028754A1 (en) Antimicrobial compositions
EP0912097B1 (fr) Compositions antimicrobiennes de peroxydase
US6228128B1 (en) Antimicrobial activity of laccases
WO2002008377A1 (fr) Compositions antimicrobiennes
JP2001522784A (ja) ラッカーゼの抗菌活性
EP1128730B1 (fr) Composition antimicrobienne a base d'oxydoreductase et d'agent facilitant du type n-hydroxyanilide
WO2001011969A1 (fr) PROCEDE ENZYMATIQUE POUR TUER OU INHIBER DES CELLULES MICROBIENNES AVEC UN Ph ELEVE
WO2001084937A1 (fr) Activite antimicrobienne induite par oxydoreductase
US20020102246A1 (en) Antimicrobial compositions
JP4071632B2 (ja) 洗濯物からの悪臭の削減
US6794350B2 (en) Reduction of malodor from laundry
US6592867B2 (en) Antimicrobial composition containing an oxidoreductase and an enhancer of the N-hydroxyanilide-type
US20020137655A1 (en) Use of haloperoxidase, peroxide and carboxylic acid
AU2002231607A1 (en) Reduction of malodour from laundry
WO2002047483A1 (fr) Utilisation de haloperoxydase, de peroxyde et d'acide carboxylique
MXPA00001369A (en) Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
CA2438510C (fr) Reduction des mauvaises odeurs emanant des buanderies
EP1030561B1 (fr) Activite antimicrobienne des lacases
US20010025018A1 (en) Antimicrobial activity of laccases
CN115605567A (zh) 医疗清洁组合物、用途以及清洁方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载